by Lorenzo Monasta | Oct 1, 2024 | Forecasting, Global Burden of Diseaase Project, Infectious diseases and AMR
By Sara Moraca A new study published in The Lancet predicts that more than 39 million people could die from antibiotic-resistant infections by 2050. This research, conducted by the Global Research on Antimicrobial Resistance (GRAM) Project, represents the first...
by Lorenzo Monasta | Mar 29, 2024 | Infectious diseases and AMR, Italian GBD Initiative
By 2050, it is estimated that antimicrobial resistance (AMR) will cause 10 million annual deaths worldwide, costing up to $100 trillion. Antibiotic resistance (ABR) is the most significant health threat and, in 2019, caused 1.27 million deaths globally. One in 5...
by Lorenzo Monasta | Mar 29, 2024 | Uncategorized
As little is known about the burden of type 1 (T1DM) and type 2 diabetes (T2DM) in adolescents in Western Europe (WE), we aimed to explore their epidemiology among 10-24 year-olds. Estimates were retrieved from the Global Burden of Diseases Study (GBD) 2019. We...
by Lorenzo Monasta | Mar 29, 2024 | Italian GBD Initiative, Non-communicable diseases
Patients with type 2 diabetes mellitus (T2DM) are rapidly increasing in Italy due to aging, preventable risk factors, and a worsening socioeconomic environment. T2DM and its consequences take a heavy toll on health care systems and the economy, given the costly...
by Lorenzo Monasta | Nov 6, 2023 | Infectious diseases and AMR, Italian GBD Initiative
In 2016, the World Health Assembly adopted the resolution to eliminate viral hepatitis by 2030. A GBD study led by the University of Milan-Bicocca, published in the journal The Lancet Public Health, aimed to provide an overview of the impact of hepatitis B virus (HBV)...
